Cigna, Centene Talk Stop-Loss, Medicaid Changes at Barclays Conference
-
Mar 14, 2025
Centene Corp. and The Cigna Group both reiterated their adjusted earnings per share (EPS) guidance for the year during Barclays 27th Annual Global Healthcare Conference on March 12. While both companies remain optimistic about their 2025 guidance, they face different pressures related to stop-loss insurance, Medicaid and more.
“We’re only two months into the year, but we continue to feel good about the earnings power of the enterprise this year and also continue to feel good about our ability to unlock the embedded earnings power that we laid out at our December Investor Day over the next few years,” said Centene CEO Sarah London while affirming the company’s EPS guidance of greater than $7.25.
Read more
© 2024 MMIT
The Latest
Meet Our Reporters
Meet Our Reporters
GAIN THERAPEUTIC AREA-SPECIFIC INTEL TO DRIVE ACCESS FOR YOUR BRAND
Sign up for publications to get unmatched business intelligence delivered to your inbox.